BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 1486304)

  • 1. Medical management of missed abortion and anembryonic pregnancy.
    el-Refaey H; Hinshaw K; Henshaw R; Smith N; Templeton A
    BMJ; 1992 Dec; 305(6866):1399. PubMed ID: 1486304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The abortifacient effect of misoprostol in the second trimester. A randomized comparison with gemeprost in patients pre-treated with mifepristone (RU486).
    el-Refaey H; Hinshaw K; Templeton A
    Hum Reprod; 1993 Oct; 8(10):1744-6. PubMed ID: 8300840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early abortion induction by a combination of mifepristone and oral misoprostol: a comparison between two dose regimens of misoprostol and their effect on blood pressure.
    el-Refaey H; Templeton A
    Br J Obstet Gynaecol; 1994 Sep; 101(9):792-6. PubMed ID: 7947529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol.
    Ashok PW; Flett GM; Templeton A
    Lancet; 1998 Aug; 352(9127):542-3. PubMed ID: 9716062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unsuccessful treatment of missed abortion with a combination of an antiprogesterone and a prostaglandin E1 analogue.
    Nielsen S; Hahlin M; Platz-Christensen JJ
    Br J Obstet Gynaecol; 1997 Sep; 104(9):1094-6. PubMed ID: 9307543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early induction of abortion by a combination of oral mifepristone and misoprostol administered by the vaginal route.
    el-Refaey H; Templeton A
    Contraception; 1994 Feb; 49(2):111-4. PubMed ID: 8143450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical methods for first trimester abortion.
    Kulier R; Gülmezoglu AM; Hofmeyr GJ; Cheng LN; Campana A
    Cochrane Database Syst Rev; 2004; (1):CD002855. PubMed ID: 14973995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol.
    Peyron R; Aubény E; Targosz V; Silvestre L; Renault M; Elkik F; Leclerc P; Ulmann A; Baulieu EE
    N Engl J Med; 1993 May; 328(21):1509-13. PubMed ID: 8479487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Assessment of efficacy and safety of medical treatment of non-viable first trimester pregnancy].
    Zwierzchowska A; Głuszak M; Jabiry-Zieniewicz Z; Banaszek-Wysoczańska A; Dziadecki W; Barcz E
    Ginekol Pol; 2012 Oct; 83(10):760-5. PubMed ID: 23383562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol.
    el-Refaey H; Rajasekar D; Abdalla M; Calder L; Templeton A
    N Engl J Med; 1995 Apr; 332(15):983-7. PubMed ID: 7885426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of abortion with mifepristone and misoprostol in early pregnancy.
    Thong KJ; Baird DT
    Br J Obstet Gynaecol; 1992 Dec; 99(12):1004-7. PubMed ID: 1477003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion.
    Honkanen H; Piaggio G; Hertzen H; Bártfai G; Erdenetungalag R; Gemzell-Danielsson K; Gopalan S; Horga M; Jerve F; Mittal S; Thi Nhu Ngoc N; Peregoudov A; Prasad RN; Pretnar-Darovec A; Shah RS; Song S; Tang OS; Wu SC;
    BJOG; 2004 Jul; 111(7):715-25. PubMed ID: 15198763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of suction curettage and mifepristone abortion in the United States. A prospective comparison study.
    Jensen JT; Astley SJ; Morgan E; Nichols MD
    Contraception; 1999 Mar; 59(3):153-9. PubMed ID: 10382077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India: a comparative trial of mifepristone-misoprostol versus surgical abortion.
    Winikoff B; Sivin I; Coyaji KJ; Cabezas E; Xiao B; Gu S; Du MK; Krishna UR; Eschen A; Ellertson C
    Am J Obstet Gynecol; 1997 Feb; 176(2):431-7. PubMed ID: 9065194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of missed abortion: comparison of medical treatment with either mifepristone + misoprostol or misoprostol alone with surgical evacuation. A multi-center trial in Copenhagen county, Denmark.
    Grønlund A; Grønlund L; Clevin L; Andersen B; Palmgren N; Lidegaard Ø
    Acta Obstet Gynecol Scand; 2002 Nov; 81(11):1060-5. PubMed ID: 12421175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of second trimester abortion (12-20 weeks) with mifepristone and misoprostol: a review of 386 consecutive cases.
    Goh SE; Thong KJ
    Contraception; 2006 May; 73(5):516-9. PubMed ID: 16627037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    BJOG; 2005 Aug; 112(8):1102-8. PubMed ID: 16045525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early pregnancy termination with mifepristone and misoprostol in the United States.
    Spitz IM; Bardin CW; Benton L; Robbins A
    N Engl J Med; 1998 Apr; 338(18):1241-7. PubMed ID: 9562577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment in miscarriage and abortion. Widened use of drugs has many advantages].
    Bygdeman M
    Lakartidningen; 1994 Apr; 91(14):1396-7. PubMed ID: 8189866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of dose of mifepristone and gestation on the efficacy of medical abortion with mifepristone and misoprostol.
    McKinley C; Thong KJ; Baird DT
    Hum Reprod; 1993 Sep; 8(9):1502-5. PubMed ID: 8253942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.